Vista Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 9.43 Cr
as on 10-07-2024
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.00 Cr
as on 10-07-2024
- Satisfied Charges ₹ 16.08 Cr
as on 10-07-2024
- Revenue 130.09%
(FY 2023)
- Profit -599.25%
(FY 2023)
- Ebitda -83.49%
(FY 2023)
- Net Worth 3.06%
(FY 2023)
- Total Assets 1.69%
(FY 2023)
About Vista Pharmaceuticals
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524711.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 9.43 Cr.
The company currently has active open charges totaling ₹17.00 Cr. The company has closed loans amounting to ₹16.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vista Pharmaceuticals Ltd. India is Suneel Pachipala as CFO. Divakar Yerrabommanahalli, Divya Chakravarthula, Umesh Banakar, and Six other members serve as directors at the Company.
- CIN/LLPIN
L24239TG1991PLC012264
- Company No.
012264
- Stock Symbol
BSE : 524711
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Jan 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Nalgonda, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vista Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneel Pachipala  | CFO | 20-Apr-2015 | Current |
| Murali Meraga | Managing Director | 14-Oct-2022 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divakar Yerrabommanahalli | Director | 30-Sep-2019 | Current |
| Divya Chakravarthula | Director | 24-Feb-2018 | Current |
Umesh Banakar  | Director | 24-Feb-2018 | Current |
| Stanley Reddy | Director | 12-Aug-2016 | Current |
| Umakanth Katta | Director | 13-Jul-2020 | Current |
| Dhananjaya Alli | Whole-Time Director | 07-Sep-2015 | Current |
Financial Performance of Vista Pharmaceuticals.
Vista Pharmaceuticals Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 130.09% increase. The company also saw a substantial fall in profitability, with a 599.25% decrease in profit. The company's net worth moved up by a moderate rise of 3.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vista Pharmaceuticals?
In 2023, Vista Pharmaceuticals had a promoter holding of 34.73% and a public holding of 65.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 23 Feb 2017 | ₹17.00 Cr | Open |
State Bank Of India Creation Date: 25 Jun 2015 | ₹8.00 Cr | Satisfied |
Allahabad Bank Creation Date: 02 May 2014 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Vista Pharmaceuticals?
Unlock and access historical data on people associated with Vista Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vista Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
